How a heart-specific RNA (HL6) helps move fat droplets inside adult heart cells
Deciphering a Novel LncRNA-mediated Lipid Droplet Transport System in Human Heart
Researchers are looking at how a human heart RNA called HL6 moves fat droplets in adult heart cells to help people with obesity- or diabetes-related heart muscle problems.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Indiana University Indianapolis NIH-funded |
| Lab location | 1 site (Indianapolis, United States) |
| Project ID | NIH-11158603 on NIH RePORTER |
What this research studies
From a patient perspective, the team will use human heart cells grown in the lab and lab-grown 3-D heart tissues to study a human long non-coding RNA named HL6. They will use gene-editing tools such as CRISPR to change HL6 levels and watch how fat-filled lipid droplets are transported inside heart cells. The work will compare normal and stressed conditions that mimic obesity or diabetes to see whether HL6 protects heart cells from fat-related damage. Findings will focus on human-specific mechanisms that could point to new ways to prevent or treat metabolic syndrome–related cardiomyopathy.
Who could benefit from this research
Good fit: Adults with metabolic syndrome, obesity, or diabetes who have signs of cardiomyopathy or who are willing to provide tissue or blood samples for research would be the most relevant candidates.
Not a fit: People with childhood-onset cardiomyopathies, purely genetic cardiomyopathies not linked to metabolic disease, or conditions unrelated to heart lipid metabolism are unlikely to benefit directly from this work.
Why it matters
Potential benefit: If successful, this work could reveal new targets for therapies or tests to reduce fat-related damage in hearts of people with obesity or diabetes.
How similar studies have performed: Previous animal and cell studies have linked some lncRNAs to lipid handling, but the HL6-driven lipid droplet transport pathway in human heart cells is novel and has not been tested before.
Where this research is happening
Indianapolis, United States
- Indiana University Indianapolis — Indianapolis, United States (Active)
Researchers
- Principal investigator: Yang, Lei — Indiana University Indianapolis
- Study coordinator: Yang, Lei
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.